Prevention of Post-Operative Nausea and Vomiting With Propofol Infusion

PHASE2CompletedINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

February 1, 2024

Primary Completion Date

March 12, 2025

Study Completion Date

March 12, 2025

Conditions
Post-operative Nausea and Vomiting
Interventions
DRUG

Propofol

Propofol is administered starting at surgery induction and ending at skin closure

OTHER

Placebo

Placebo is administered starting at surgery induction and ending at skin closure

Trial Locations (1)

17033

Penn State Health Milton S Hershey Medical Center, Hershey

All Listed Sponsors
lead

Milton S. Hershey Medical Center

OTHER

NCT05759481 - Prevention of Post-Operative Nausea and Vomiting With Propofol Infusion | Biotech Hunter | Biotech Hunter